Generali Asset Management SPA SGR

Position in ZTS — Zoetis Inc.

CIK 2046751 TRIESTE, L6

Back to ZTS Full portfolio

Position in ZTS

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$4,105,936

-$2,080,466 QoQ

Shares Held

57,138

+9.2% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#369

of 1,408 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 29% Shared 0% None 71%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Generali Asset Management SPA SGR holds $7,610,582 across 3 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (54.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc. This page	57,138	$4,105,936
2	NBIX	Neurocrine Biosciences Inc	17,425	$2,936,809
3	UTHR	UNITED THERAPEUTICS Corp	1,048	$567,837

All Filings in ZTS

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,105,936	57,138	+9.2%	Shares	Sole	2026-07-30
2026-03-31	$6,186,402	52,334	+29.9%	Shares	Sole	2026-05-05
2025-12-31	$5,070,797	40,302	-26.8%	Shares	Sole	2026-02-03
2025-09-30	$8,057,549	55,068	+4.3%	Shares	Sole	2025-10-21
2025-06-30	$8,236,655	52,816	+5.1%	Shares	Sole	2025-07-28
2025-03-31	$8,274,321	50,254	-21.7%	Shares	Sole	2025-05-15
2024-12-31	$10,457,010	64,181	—	Shares	Sole	2025-05-29
No filing history on record for this holder in this stock.